VirusDisease Virology

In silico design and immune simulation of a multi-epitope subunit vaccine candidate of marburg virus: structural validation and receptor interaction analysis

Kurmi, Santosh Prasad Chaudhary, Nath, Subrata, Mishra, Vipin Kumar, Kurmi, Suneel Kumar, Sarma, Arnabjyoti Deva, Devi, Moitrayee, Gupta, Roma Kumari, Murav, Ashok Kumar
Springer Nature · 2026-10-13 · DOI 10.1007/s13337-026-00987-5

Abstract

Marburg virus (MARV) is an extremely virulent pathogen for which effective preventive and therapeutic strategis remain limited, highlighting the urgent demand for a safe and efficient vaccine. In this study, an immunoinformatics-based approach was employed to design a novel multi-epitope subunit vaccine capable of eliciting robust humoral and cell mediated immune responses. Highly conserved cytotoxic T lymphocyte (CTL), helper T lymphocyte (HTL), and B-cell epitopes were systematically predicted and assembled using GGGS, GPGPG and KK linkers respectively. To enhance immunogenicity, the construct was fused with the 50S ribosomal protein L7/L12 as an adjuvant, while a PADRE sequence was incorporated to promote broad CD4^+ T-cell activation across diverse HLA alleles. The three-dimensional structure of the vaccine construct was modelled, refined and evaluated for stability and structural integrity using validation tools including ERRAT, Ramachandran plot analysis, MolProbity scoring, and RMSD assessment. Molecular docking studies revealed strong and stable interactions between the vaccine and immune receptors, as reflected by a favourable HDOCK score (− 315.21) and a high confidence value (0.9646). Additionally, normal mode analysis conducted via iMODS demonstrated appropriate molecular flexibility, indicated by a low eigen value (3.61×10^–6), supporting effective receptor engagement and immune activation. Immune simulations revealed strong humoral and cellular immune responses, marked by increased levels of IgG and IgM, cytokine secretion (IFN-γ, IL-2, TNF-α), and the development of memory cells. The optimized gene attained a Codon Adaptation Index (CAI) of 1.0 along with a GC content of 54.49%, indicating its appropriateness for expression in Escherichia coli utilizing the pET-28a( +) vector. In summary, the Insilico results present the constructed vaccine as a promising multi-epitope candidate against the Marburg virus, necessitating additional experimental tests to validate its immunogenic effectiveness and protective capability.

Read at publisher →